Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000271456 | SCV000344853 | uncertain significance | not provided | 2016-08-15 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001082195 | SCV000463870 | uncertain significance | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Labcorp Genetics |
RCV000271456 | SCV000641772 | likely benign | not provided | 2025-01-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000271456 | SCV001822778 | uncertain significance | not provided | 2020-12-15 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign in association with methylmalonic acidemia to our knowledge; This variant is associated with the following publications: (PMID: 28337550) |
ARUP Laboratories, |
RCV001082195 | SCV002048159 | uncertain significance | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | 2022-03-17 | criteria provided, single submitter | clinical testing | The MMUT c.1125G>A; p.Met375Ile variant (rs148091558) is reported in the literature in individuals affected with multiple sclerosis, but is also found in healthy controls (Traboulsee 2017). This variant is also reported in ClinVar (Variation ID: 290321), and is found in the general population with an overall allele frequency of 0.16% (438/282374 alleles) in the Genome Aggregation Database. The methionine at codon 375 is highly conserved, and computational analyses predict that this variant is deleterious (REVEL: 0.853). Due to limited information, the clinical significance of the p.Met375Ile variant is uncertain at this time. References: Traboulsee AL et al. Common genetic etiology between "multiple sclerosis-like" single-gene disorders and familial multiple sclerosis. Hum Genet. 2017 Jun;136(6):705-714. PMID: 28337550. |
Revvity Omics, |
RCV001082195 | SCV003808871 | uncertain significance | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | 2022-06-07 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001276751 | SCV001463279 | uncertain significance | Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency | 2019-12-27 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003940077 | SCV004754655 | likely benign | MMUT-related disorder | 2022-05-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |